UBS
EQLTS.SW
LU1215452092
UBS Factor MSCI EMU Quality Screened UCITS ETF hCHF acc
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
21.58
Weighted Fwd P/E
17.34
Avg P/FCF
23.65
Avg FCF Yield
3.57%
Avg EV / EBITDA
19.03
Avg EV / Revenue
5.78
Avg Price-to-Book (P/B)
8.1
Avg Price-to-Sales (P/S)
5.75
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
-19.68%
Avg Debt-to-Equity (D/E)
54.89%
<50% (56.82%) 50-150% (35.05%) >150% (5.32%) Unreported (2.81%)

Profitability Analysis

60 Holdings Count
Profitable 100%
Profitable 100%
60 Holdings Count (100%)
Unprofitable 0%
0 Holdings Count (0%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

Moderate Concentration
Top 5
26.7%
Top 10
40.7%
Top 25
72.8%
50% Threshold
Top 14
The top 10 positions account for 40.7% of the portfolio. A healthy balance between a strong core and diversification. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

11 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (6.7%+)
High (17.5%+)
Top (24.2%+)

Country Breakdown

Max: 26.85%
DE DE DE
26.85%
NL NL NL
22.63%
FR FR FR
16.71%
IT IT IT
9.76%
FI FI FI
8.42%
ES ES ES
6.42%
GB GB GB
2.44%
IE IE IE
1.98%
BE BE BE
1.62%
AT AT AT
0.58%
US US US
0.41%

Sector Distribution

9 Sector
Technology
23.73%
Financial Services
21.52%
Consumer Defensive
15.09%
Industrials
13.40%
Consumer Cyclical
9.70%
Healthcare
5.50%
Communication Services
5.39%
Utilities
3.45%
Other
0.05%

Industry Distribution

36 Industries
Semiconductor Equipment & Materials
15.69%
Insurance - Diversified
10.16%
Specialty Industrial Machinery
7.89%
Household & Personal Products
7.01%
Software - Application
6.04%
Packaged Foods
4.81%
Insurance - Reinsurance
4.31%
Drug Manufacturers - Specialty & Generic
3.24%
Other
38.66%

Market Cap Distribution

60 Holdings Count
Mega Cap (> 200B)
(3) 18.20%
Large Cap (10B - 200B)
(50) 75.33%
Mid Cap (2B - 10B)
(7) 4.29%
ende